Association between fibroblast growth factor 7 and the risk of chronic obstructive pulmonary disease

Acta Pharmacologica Sinica

Volumn 33, Issue 8, 2012, Pages 998-1003

  Xu, Si Cheng ^a   Kuang, Jiang Ying ^a   Liu, Jin ^a   Ma, Chun Lan ^a   Feng, Yu Lin ^a   Su, Zhi Guang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

chronic obstructive pulmonary disease; fibroblast growth factor 7; genetic polymorphism; haplotype

Indexed keywords

KERATINOCYTE GROWTH FACTOR; FGF7 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; GENETICS; MIDDLE AGED; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 7; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84864681464     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.69     Document Type: Article

References (30)

1. Murray CJ, Lopez AD. Evidence-based health policy\lessons from the Global Burden of Disease Study. Science 1996; 274: 740-3. (Pubitemid 26398244)
2. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-60. (Pubitemid 47598476)
3. Davis RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: S82-4. (Pubitemid 19231340)
4. Khoury MJ, Beaty TH, Tockman MS, Self SG, Cohen BH. Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors. Genet Epidemiol 1985; 2: 155-66. (Pubitemid 15027436)
5. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet 2010; 19: 526-34.
6. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010; 43: 200-2.
7. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5: e1000421.
8. Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, Brandler BJ, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009; 5: e1000429.
9. Ulich TR, Yi ES, Longmuir K, Yin S, Biltz R, Morris CF, et al. Keratino-cyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 1994; 93: 1298-306. (Pubitemid 24087188)
10. Yano T, Mason RJ, Pan T, Deterding RR, Nielsen LD, Shannon JM. KGF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1146-58. (Pubitemid 32009501)
11. Peters K, Werner S, Liao X, Wert S, Whitsett J, Williams L. Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO J 1994; 13: 3296-301. (Pubitemid 24226944)
12. Simonet WS, DeRose ML, Bucay N, Nguyen HQ, Wert SE, Zhou L, et al. Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung. Proc Natl Acad Sci USA 1995; 92: 12461-5. (Pubitemid 26014089)
13. Cardoso WV, Itoh A, Nogawa H, Mason I, Brody JS. FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium. Dev Dyn 1997; 208: 398-405. (Pubitemid 27114292)
14. Prince LS, Karp PH, Moninger TO, Welsh MJ. KGF alters gene expression in human airway epithelia: potential regulation of the infammatory response. Physiol Genomics 2001; 6: 81-9. (Pubitemid 33676476)
15. Baba Y, Yazawa T, Kanegae Y, Sakamoto S, Saito I, Morimura N, et al. Keratinocyte growth factor gene transduction ameliorates acute lung injury and mortality in mice. Hum Gene Ther 2007; 18: 130-41. (Pubitemid 46446050)
16. Sakamoto S, Yazawa T, Baba Y, Sato H, Kanegae Y, Hirai T, et al. Keratinocyte growth factor gene transduction ameliorates pulmonary fibrosis induced by bleomycin in mice. Am J Respir Cell Mol Biol 2011; 45: 489-97.
17. Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, infammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002; 282: L924-40. (Pubitemid 34654608)
18. Riley BM, Mansilla MA, Ma J, Daack-Hirsch S, Maher BS, Raffens-perger LM, et al. Impaired FGF signaling contributes to cleft lip and palate. Proc Natl Acad Sci USA 2007; 104: 4512-7. (Pubitemid 47186256)
19. Teumer A, Rawal R, Homuth G, Ernst F, Heier M, Evert M, et al. Genome-wide association study identifies four genetic loci associated with thyroid volume and goiter risk. Am J Hum Genet 2011; 88: 664-73.
20. Brehm JM, Hagiwara K, Tesfaigzi Y, Bruse S, Mariani TJ, Bhattacharya S, et al. Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax 2011; 66: 1085-90.
21. Su ZG, Wen FQ, Feng YL, Xiao M, Wu XL. Transforming growth factor-beta1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol Sin 2005; 26: 714-20. (Pubitemid 40806561)
22. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003; 22: 1-2. (Pubitemid 36896461)
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300.
24. Silverman EK, Palmer LJ. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 2000; 22: 645-8. (Pubitemid 30400241)
25. Morris RW, Kaplan NL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-33.
26. Silverman EK, Palmer LJ, Mosley JD, Barth M, Senter JM, Brown A, et al. Genomewide linkage analysis of quantitative spirometric pheno-types in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70: 1229-39. (Pubitemid 34450572)
27. Korb M, Ke YB, Johnson LF. Stimulation of gene expression by introns: conversion of an inhibitory intron to a stimulatory intron by alteration of the splice donor sequence. Nucl Acids Res 1993; 21: 5901-8. (Pubitemid 24023705)
28. Gaspar P, Moreira J, Kvitko1 K, Torres M, Moreira A, Weimer T. CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1, and TP53 polymorphisms: do they indicate susceptibility to chronic obstructive pulmonary disease and non-small-cell lung cancer? Genet Mol Biol 2004; 27: 133-8. (Pubitemid 43084825)
29. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998; 351: 1911-3. (Pubitemid 28297446)
30. Seersholm N, Wilcke JT, Kok-Jensen A, Dirksen A. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin hetero zygotes of phenotype PiMZ. Am J Respir Crit Care Med 2000; 161: 81-4. (Pubitemid 30055906)